Altered hepatic gene expression profiles associated with myocardial ischemia

Area of Science:

• Cardiovascular Research
• Hepatic Physiology
• Molecular Biology

Background:

• Acute coronary syndrome involves systemic changes beyond the heart, including altered coagulability, lipid metabolism, and inflammation.
• The liver's role in acute coronary syndrome pathophysiology is under-investigated.
• This study explores the liver's response to acute myocardial ischemia.

Purpose of the Study:

• To investigate the liver's gene expression changes during acute myocardial ischemia.
• To identify potential cardiac-derived factors influencing hepatic responses.
• To elucidate the molecular mechanisms linking cardiac events and liver function.

Main Methods:

• Simultaneous analysis of liver and heart gene expression profiles in mice subjected to myocardial ischemia.
• Comparison of gene expression in myocardial infarction and liver ischemia/reperfusion models.
• In vitro studies using primary hepatocytes and osteopontin treatment.

Main Results:

• Myocardial ischemia significantly altered hepatic gene expression, upregulating genes involved in tissue remodeling, adhesion, and morphogenesis.
• These hepatic changes were specific to cardiac events, not liver ischemia.
• Osteopontin, released from the heart, was identified as a humoral factor that modifies hepatocyte signaling and stimulates vascular endothelial growth factor-A secretion.

Conclusions:

• Cardiac humoral factors, such as osteopontin, can regulate hepatic gene expression during myocardial ischemia.
• These findings offer novel insights into the systemic pathophysiology of acute coronary syndrome.
• The heart-liver axis represents a potential therapeutic target for acute coronary syndrome.